T cell proliferative responses of type 1 diabetes patients and healthy individuals to human hsp60 and its peptides

被引:100
作者
Abulafia-Lapid, R
Elias, D
Raz, I
Keren-Zur, Y
Atlan, H
Cohen, IR [1 ]
机构
[1] Weizmann Inst Sci, Dept Immunol, IL-76100 Rehovot, Israel
[2] Hadassah Univ Hosp, Dept Biophys & Nucl Med, HBRC, IL-91120 Jerusalem, Israel
[3] Hadassah Univ Hosp, Dept Internal Med, IL-91120 Jerusalem, Israel
关键词
hsp60; type 1 insulin-dependent diabetes; T-cell immunity; autoimmunity;
D O I
10.1006/jaut.1998.0262
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
T cell responses to peptide epitopes of the 60 kDa heat shock protein (hsp60) have been shown to play a role in the pathogenesis of type 1 insulin-dependent diabetes mellitus (IDDM) in mice. To test whether hsp60 autoimmunity might be involved in human type 1 diabetes, we studied T cell proliferative responses (stimulation index; SI) to intact human hsp60, to hsp60 peptides and to a recall antigen (tetanus toroid) in 25 newly diagnosed type 1 diabetes patients, in 22 type 2 (non-insulin-dependent diabetes mellitus, NIDDM) patients, and in 25 healthy blood donors. There were no significant differences between the T cell responses of the three groups to tetanus toroid. However, the responses to hsp60 of the type 1 diabetes group (median SI=5) were significantly greater (P<0.01) than those of the type 2 group (median SI=1.67) and of the blood donors (median SI=1.7). Epitope mapping revealed significant responses to at least seven different peptides, with prevalent responses to the p277 peptide previously mapped in NOD mice and to peptide p32. Thus, newly diagnosed type 1 diabetes patients, similar to prediabetic and newly diabetic NOD mice, show heightened autoimmunity to hsp60 and hsp60 peptides. (C) 1999 Academic Press.
引用
收藏
页码:121 / 129
页数:9
相关论文
共 32 条
[1]  
ATKINSON MA, 1994, NEW ENGL J MED, V331, P1428
[2]   RESPONSE OF PERIPHERAL-BLOOD MONONUCLEAR-CELLS TO GLUTAMATE-DECARBOXYLASE IN INSULIN-DEPENDENT DIABETES [J].
ATKINSON, MA ;
KAUFMAN, DL ;
CAMPBELL, L ;
GIBBS, KA ;
SHAH, SC ;
BU, DF ;
ERLANDER, MG ;
TOBIN, AJ ;
MACLAREN, NK .
LANCET, 1992, 339 (8791) :458-459
[3]   CELLULAR-IMMUNITY TO A DETERMINANT COMMON TO GLUTAMATE-DECARBOXYLASE AND COXSACKIE-VIRUS IN INSULIN-DEPENDENT DIABETES [J].
ATKINSON, MA ;
BOWMAN, MA ;
CAMPBELL, L ;
DARROW, BL ;
KAUFMAN, DL ;
MACLAREN, NK .
JOURNAL OF CLINICAL INVESTIGATION, 1994, 94 (05) :2125-2129
[4]   INSULIN-DEPENDENT DIABETES-MELLITUS AS AN AUTOIMMUNE-DISEASE [J].
BACH, JF .
ENDOCRINE REVIEWS, 1994, 15 (04) :516-542
[5]   A role of Hsp60 in autoimmune diabetes: Analysis in a transgenic model [J].
Birk, OS ;
Douek, DC ;
Elias, D ;
Takacs, K ;
Dewchand, H ;
Gur, SL ;
Walker, MD ;
vanderZee, R ;
Cohen, IR ;
Altmann, DM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (03) :1032-1037
[6]   NOD mouse diabetes: The ubiquitous mouse Hsp60 is a beta-cell target antigen of autoimmune T cells [J].
Birk, OS ;
Elias, D ;
Weiss, AS ;
Rosen, A ;
vanderZee, R ;
Walker, MD ;
Cohen, IR .
JOURNAL OF AUTOIMMUNITY, 1996, 9 (02) :159-166
[7]   Treatment of NOD diabetes with a novel peptide of the hsp60 molecule induces th2-type antibodies [J].
Bockova, J ;
Elias, D ;
Cohen, IR .
JOURNAL OF AUTOIMMUNITY, 1997, 10 (04) :323-329
[8]   The Th1/Th2 dichotomy, hsp60 autoimmunity, and type I diabetes [J].
Cohen, IR .
CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY, 1997, 84 (02) :103-106
[9]   Cellular immune response to diverse islet cell antigens in IDDM [J].
DurinovicBello, I ;
Hummel, M ;
Ziegler, AG .
DIABETES, 1996, 45 (06) :795-800
[10]   INDUCTION OF DIABETES IN STANDARD MICE BY IMMUNIZATION WITH THE P277 PEPTIDE OF A 60-KDA HEAT-SHOCK PROTEIN [J].
ELIAS, D ;
MARCUS, H ;
RESHEF, T ;
ABLAMUNITS, V ;
COHEN, IR .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1995, 25 (10) :2851-2857